FDA Provides Manufacturing Clearance For Phase III Trial Of Anti-Cancer Drug
Published by FDA - Topix.net November 30th, 2006 in UncategorizedProgen Industries today announced it has received notification from the U.S. FDA that the appropriate CMC procedures have been put in place to progress its anti-cancer drug PI-88 to Phase III clinical trials.
Comment